More articles about: drugs
Health Lab Podcast
7-OH, kratom and the emerging public health crisis for sale across the country
A patient, his doctor and other experts warn of dangers of 7-OH, which is touted as a derivative of kratom and is widely available, but packs far more opioid danger.
Health Lab Podcast
Studying the relationship between cancer and fish oil
ALOX15 loss, which is common in colorectal tumors, impairs the cancer-preventative effects of fish oil. Read the full article on Health Lab.
The Fundamentals
Opioids and Respiratory Depression
The main cause of death due to opioid overdose is respiratory depression. In other words, the brain of a person under the influence of opioids can simply forget to breathe. In today’s episode, we talk with Dr. Erica Levitt, associate professor in the Departments of Pharmacology and Anesthesiology at University of Michigan Medical School, who is trying to explain this connection, with the hope of maintaining the powerful pain relieving effects of opioids without their potentially deadly effects.
Health Lab
The solution to death from a fentanyl overdose could lie in its chemical structure
University of Michigan researchers may have found that the solution to prevent people from dying from a fentanyl overdose may be found within fentanyl's own chemistry.
Health Lab Podcast
The parallel market of hemp-derived alternative cannabis products, and the potential harm they pose
A lack of regulation around CBD, Delta-8 and other cannabinoids could open up consumers to harm. Visit Health Lab to read the full story.A lack of regulation around CBD, Delta-8 and other cannabinoids could open up consumers to harm.
Health Lab Podcast
A new pill for postpartum depression?
The fast-acting pill, paired with psychosocial treatment, offers a comprehensive treatment plan, but price concerns remain. Visit Health Lab to read the full story.
Minding Memory
Lecanemab: Breakthrough Alzheimer’s Disease Medication Déjà vu
In this episode of Minding Memory, we dive into the newest FDA-approved drug to treat Alzheimer’s – Lecanemab – with Ohio State University stroke neurologist Jim Burke. Dr. Burke discusses the benefits and drawbacks of the new Alzheimer’s drug and also the paradigm shift of how people (clinicians, patients, and the general population) are thinking about these news Alzheimer’s medications.
Health Lab Podcast
Could Prostate Cancer Drugs Help Fight COVID Infections?
Researchers look into a drug called proxalutamide as a potential therapeutic for the coronavirus.
Health Lab Podcast
Fentanyl Overdose Awareness
Community awareness is critical to preventing overdose
Health Lab Podcast
Reducing Delayed Dispensing for Opioids
Hundreds of thousands of surgical and dental opioid prescriptions are filled a month or more after writing, but one state’s law helped reduce this “delayed dispensing”.
Minding Memory
Drugs and Dementia: The Good, the Bad, and the Ugly
While there are some FDA-approved medications for dementia, more individuals living with dementia are actually prescribed psychotropic medications. In this episode, Donovan introduces Matt to the concept of the behavioral and psychological symptoms of dementia, which are just as much part of dementia as the memory loss—and are probably a big reason for all this other prescribing.
Minding Memory
What are the Implications of the Approval of Aduhelm (Aducanumab) to the US Healthcare System?
In this episode we continue our discussion of the implications of the approval of Aducanumab. Our guest this week is Professor Nicholas Bagley. Prof. Bagley is a professor of law at the University of Michigan Law School and a contributing writer to the Atlantic. Recently he wrote an article titled “The Drug that Could Break American Health Care” that discusses some of the broader (unintended) consequences of the approval of Aducanumab. In this episode we discuss some of the broader cost implications of the new drug.
Minding Memory
Could the FDA’s Approval of a New Drug to Treat Alzheimer’s Disease do More Harm than Good?
Aducanumab is a new drug designed to remove amyloid in the brain. Following an accelerated process, the Food and Drug Administration approved Aducanumab as a treatment for Alzheimer’s disease despite (what many experts feel) little evidence of effectiveness. In this episode we discuss the approval of Aducanumab with Dr. Jason Karlawish from the University of Pennsylvania and talk about what it could mean for drug discovery going forward.
Health Lab
Dr. Vydiswaran’s Michigan Answer: Better outcomes through big data
Nearly all of us engage with some form of social media every day. But what if the true power of social media wasn’t found in a like, tweet or follow? For an emerging field of research taking place at Michigan Medicine, it’s the data inside social media that may have the power to give patients bigger answers and better outcomes.
